According to a recent study, caffeine consumption may be associated with milder liver fibrosis in patients suffering from chronic hepatitis C.
Researchers at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) found that 308 mg of caffeine, or approximately 2.5 cups of coffee, may have a therapeutic effect on patients afflicted with the disease.
The study found that respondents with a moderate level of fibrosis averaged a caffeine intake of 212 mg per day while patients with severe levels of liver scarring consumed only 154 mg on a daily basis.
For each 67 mg increase in the compound, participants saw a 14 percent decrease in the odds of having advanced fibrosis.
"From data collected to date it remains unclear whether coffee itself or caffeine provides the beneficial effect," said lead author Apurva Modi.
Approximately 71 percent of total caffeine consumed in the study was associated with coffee. Researchers are still unclear whether soft drinks, tea and cocoa include beneficial properties.